Volume 47, Issue S1 - Supplement: EUROMEDLAB Innsbruck 2009

Laboratory diagnostics – lessons from clinical trials and epidemiological studies Glicomics - state of the art The stress response and intracellular signalling The environment and laboratory diagnostics: new opportunities and new duties

1st Congress of the European Society of Predictive Medicine

Cardiovascular diseases Clinical toxicology How to define and determine reference intervals and decision limits in laboratory medicine Biobanking concepts – need for an integrated European solution Vitamin D metabolites in cancer, immunological and cardiovascular diseases From stem cells to cardiovascular therapy Screening and identifying small to large molecules in clinical chemistry by mass spectrometry Quality management in Europe – implementation of ISO-15189 Diabetes mellitus, atherosclerosis, renal failure – ‘post translational pathologies’ Pediatric reference ranges Standardization activities in endocrinology Proteomics and human diseases Translational research: re-engineering the laboratory medicine enterprise Pharmacogenetics in laboratory medicine: from bench to bedside Update on cardiovascular markers Frontiers in molecular haemato-oncology Genomic instability syndrome Evidence-based evaluation of new specialized tests and their cost-effectiveness Obesities, diabetes type II and metabolic syndrome; new clinical and diagnostic ways Modern concepts in external quality assurance New biological markers in neurological disorders: presence & future Diagnosis and management of bone and joint diseases Biology and diagnostics of renal function Autoimmune diseases Laboratory performance and patient safety Frontiers in therapeutic drug monitoring POCT: models for delivery in hospitals, GP practice and home. Ensure quality and improved patient outcome Genetic disorders of body fluid homeostasis Guidelines for pharmacogenetics/an IFCC integrated project Biostatistics

Use of biomarkers in heart disease Standardisation of HbA1c The power of networking Personnalized health care – what it takes to be a leader Integrated diagnostics – what do you think the next generation of healthcare will look like? Biochips can save lives: cardiovascular disease The future and importance of solution business What is new on cardiac troponin? Diagnostic performance and clinical value of holotranscobalamin, measured by the AxSYM Active-B12 assay, for vitamin B12 status Directing the spotlight on renal disease Automation solutions for laboratories in hospital networks Beyond blood Complementary role of serology and NAT in the diagnosis of viral hepatitis New developments in prostate cancer management Advances in clinical diagnostics by LC-MS/MS – novel diagnostic kits & quality controls and their value for routine clinical laboratories The clinical value of serum HER-2/neu in breast cancer patients – an update The urinary sediment: an update Roche Diagnostics new offering for high volume laboratories. cobas 8000 modular analyzer: a new dimension of efficiency and productivity Prevention and early detection of gynecological cancer Current and future perspectives with cardiac biomarkers Managing urinary tract infection (UTI) – still a challenge? Advances in reproductive endocrinology and high-risk pregnancy testing Biochips to advance research Recent advances in the management of free light chain disease The appropriate application of Lean Haemolysis: causes, affects, prevalence, measurement & solutions in pathology Pentra 400 ® evaluation for therapeutic drug monitoring and drug abuse testing Learn how VITROS ® Diagnostic Systems help you optimize productivity in your laboratory by using objective metrics Vitamin D osteoporosis and beyond